GlassScriptPhysician profile
Peter Stevens Fail
NPI 1437156429
$206,197.23
in general payments reported to CMS, 2019-2025
40 companies · $10K in 2025
The $10K reported for 2025 was more than what 77% of Advanced Heart Failure and Transplant Cardiology providers received nationally (typical 2025 total: $1,046).
See the full distribution for Advanced Heart Failure and Transplant Cardiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29K · 2020: $9,024 · 2021: $68K · 2022: $20K · 2023: $36K · 2024: $33K · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $29K · Consulting Fee: $24K · Food and Beverage: $14K · Travel and Lodging: $13K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $28,800.00 |
| Consulting Fee | $23,625.00 |
| Food and Beverage | $14,147.14 |
| Travel and Lodging | $12,998.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $95,896.45 | 2021-2025 | Corevalve Evolut R, Symplicity G3, In.Pact Admiral |
| Abbott Laboratories | $47,265.71 | 2019-2025 | Mitraclip, Amplatzer Amulet, Triclip |
| Medtronic Vascular, INC. | $31,647.97 | 2019-2020 | |
| Atricure, INC. | $15,000.00 | 2022-2023 | |
| Edwards Lifesciences Corporation | $7,349.45 | 2019-2025 | Pascal, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Evoque |
| Ancora Heart, INC. | $2,256.08 | 2019-2025 | Accucinch |
| Boston Scientific Corporation | $2,174.99 | 2019-2024 | Watchman Access System, Carotid Wallstent |
| W. L. Gore & Associates, INC. | $674.96 | 2019-2023 | Gore Tag Thoracic Endoprosthesis, Gore Cardioform Septal Occluder |
| Cardiac Dimensions, INC. | $480.28 | 2024-2025 | |
| Amgen INC. | $414.99 | 2019-2025 | Repatha |
| Penumbra, INC. | $376.48 | 2022-2025 | Ruby Coil, Smart Coil |
| E.R. Squibb & Sons, L.L.C. | $372.83 | 2024-2025 | Camzyos, Eliquis |
| Abiomed | $354.79 | 2019-2025 | Impella |
| Astrazeneca Pharmaceuticals LP | $296.65 | 2019-2024 | Farxiga |
| Pfizer INC. | $208.12 | 2019-2025 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $165.84 | 2025 | Angiovac, Alphavac |
| Kestra Medical Technology Services, INC. | $130.65 | 2023-2025 | Assure Wcd |
| Shockwave Medical, INC | $123.92 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Terumo Medical Corporation | $119.75 | 2025 | R2p Misago, Azur Cx Detachable, Tubing Kit - Stroke |
| Astellas Pharma US INC | $118.89 | 2022 | |
| Silk Road Medical, INC. | $109.01 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Medicure Pharma INC. | $100.00 | 2020 | |
| Merck Sharp & Dohme LLC | $91.36 | 2025 | Winrevair |
| Imperative Care, INC | $71.33 | 2023 | Symphony Catheter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $68.15 | 2022-2023 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $63.90 | 2022-2023 | Lifevest |
| Cardiovascular Systems INC. | $59.50 | 2019 | |
| Janssen Pharmaceuticals, INC | $58.05 | 2019-2021 | |
| Impulse Dynamics (USA) INC. | $29.47 | 2023 | Optimizer |
| Contego Medical, INC | $24.41 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $24.25 | 2025 | Evkeeza |
| Cardiva Medical, INC. | $19.72 | 2024 | Ensoetm |
| Gilead Sciences, INC. | $17.63 | 2019 | |
| Celonova Biosciences, INC. | $15.92 | 2019 | |
| Bard Peripheral Vascular, INC. | $15.73 | 2022 |
5 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5,200.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Fail listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.